Live Analyst Rating Changes 1525 upgrades, downgrades & price-target moves · freshest Wall Street data, updated daily View live feed →
Analyst Tracker/Allison Bratzel
PIPR
Allison Bratzel
Piper Sandler
Wall Street Analyst
★★★☆☆
#1428
on 13Foresight · ranked by our own returns
50%
Success Rate
+7.0%
Average Return
14 of 28 calls profitable · +0.4% vs benchmark
📈 Across the calls we could measure, roughly 50% of Allison Bratzel's ratings turned a profit when each position was held for 2 year — averaging +7.0% per rating. These figures are computed by 13Foresight from historical prices, not supplied by the analyst.

Rating Distribution

86 Buy 19 Hold 0 Sell
Allison's Stock Coverage 25 ratings · 2026-06-20
Company Date Position Consensus ⓘ Price Target ⓘ 2-Yr Return
HUMA
Humacyte
 Jun 18, 2026 HOLD Strong Buy
+665.4% avg upside
11 analysts
$1.00
8.24% Upside
 ·
ABVX
Abivax SA Sponsored ADR
 Jun 16, 2026 BUY Strong Buy
+20.7% avg upside
15 analysts
$165.00
66.40% Upside
 +2.7%
INCY
Incyte
 Jun 09, 2026 BUY Buy
+1.0% avg upside
47 analysts
$110.00
11.98% Upside
 -4.1%
TVTX
Travere Therapeutics
 Jun 03, 2026 BUY Strong Buy
-16.0% avg upside
22 analysts
$49.00
11.14% Downside
 +15.1%
BMRN
BioMarin Pharmaceutical
 May 21, 2026 BUY Strong Buy
+72.8% avg upside
52 analysts
$82.00
49.94% Upside
 +1.7%
RIGL
Rigel
 May 13, 2026 HOLD Strong Buy
-27.5% avg upside
17 analysts
$40.00
21.56% Upside
 +1.8%
ALXO
ALX Oncology Holdings
 May 11, 2026 BUY Strong Buy
+1072.8% avg upside
11 analysts
$4.00
161.45% Upside
 -30.3%
ARGX
Argenx Se
 May 11, 2026 BUY Strong Buy
-15.9% avg upside
46 analysts
$1075.00
22.46% Upside
 +8.5%
ENGN
enGene Holdings
 May 08, 2026 HOLD Buy
+481.4% avg upside
13 analysts
$4.00
132.50% Upside
 +16.7%
CDXS
Codexis
 May 08, 2026 BUY Strong Buy
+291.5% avg upside
13 analysts
$9.00
250.15% Upside
 -13.7%
COGT
Cogent Biosciences
 May 07, 2026 BUY Strong Buy
+7.1% avg upside
26 analysts
$52.00
50.61% Upside
 -1.6%
RARE
Ultragenyx Pharmaceutical
 May 07, 2026 BUY Strong Buy
+142.1% avg upside
36 analysts
$68.00
147.73% Upside
 -11.6%
ARDX
Ardelyx
 May 01, 2026 BUY Strong Buy
+124.0% avg upside
21 analysts
$16.00
164.52% Upside
 -19.5%
AKBA
Akebia Therapeutics
 Apr 24, 2026 BUY Strong Buy
+822.0% avg upside
16 analysts
$4.00
273.77% Upside
 -34.5%
IONS
Ionis Pharmaceuticals
 Apr 24, 2026 BUY Strong Buy
+13.3% avg upside
43 analysts
$100.00
34.86% Upside
 +0.0%
MGTX
Meiragtx Holdings
 Apr 22, 2026 BUY Strong Buy
+130.4% avg upside
13 analysts
$30.00
165.03% Upside
 -4.4%
IMRX
Immuneering
 Apr 21, 2026 BUY Strong Buy
+303.9% avg upside
10 analysts
$12.00
172.13% Upside
 -7.0%
REPL
Replimune Group
 Apr 10, 2026 HOLD Hold
+72.3% avg upside
13 analysts
$4.00
60.82% Downside
 +114.1%
BHVN
Biohaven Ltd.
 Mar 24, 2026 BUY Strong Buy
+87.5% avg upside
25 analysts
$30.00
121.02% Upside
 +61.7%
TYRA
Tyra Bioscience
 Mar 20, 2026 BUY Strong Buy
+57.9% avg upside
17 analysts
$56.00
97.82% Upside
 -21.8%
SRRK
Scholar Rock Holding
 Mar 04, 2026 BUY Strong Buy
+20.1% avg upside
23 analysts
$58.00
22.45% Upside
 -1.0%
IOBTQ
IO Biotech
 Jan 23, 2026 HOLD Buy
+78483.3% avg upside
6 analysts
$0.50
8233.29% Upside
 ·
ABCL
AbCellera Biologics
 Jul 28, 2025 BUY Strong Buy
+137.9% avg upside
15 analysts
$17.00
207.39% Upside
 -10.4%
ROIV
Roivant Sciences
 Jul 18, 2024 BUY Strong Buy
+2.5% avg upside
17 analysts
$22.00
29.93% Downside
 +180.8%
SLDB
Solid Biosciences
 Mar 14, 2024 BUY Strong Buy
+90.3% avg upside
23 analysts
$20.00
140.17% Upside
 -40.5%
🔒 20 more ratings — with price targets, crowd consensus and our measured returns.
Sign in free to unlock See Pro plans
Free account unlocks every analyst's full coverage table.
Allison Bratzel — Frequently Asked Questions
How accurate are Allison Bratzel's stock ratings?
Based on the calls 13Foresight could measure, about 50% of Allison's ratings were profitable over a one-year hold, with an average return of +0.0% per rating, or -5.0% versus the S&P 500. We score every analyst the same way, from historical prices.
How is Allison ranked on 13Foresight?
Allison Bratzel is currently ranked #1428 with a 3-star rating. Our rank blends hit rate, average return versus the market, and how many calls we have to judge — so a long, consistent record outweighs a few lucky picks. It is our own calculation, updated daily.
Which stocks does Allison cover?
Allison most recently has ratings on HUMA, ABVX, INCY, TVTX, BMRN, RIGL, ALXO, ARGX, ENGN, CDXS, COGT, RARE and 13 more. See the full coverage table above for positions, price targets and our measured returns.
Where can I see other analyst ratings?
Browse the full analyst leaderboard to compare Wall Street analysts ranked by their measured performance, success rate and average return.

Disclaimer: 13Foresight compiles analyst ratings and price targets from publicly available sources. Performance metrics, rankings and star ratings shown here are calculated independently by 13Foresight from historical market prices and may differ from figures published elsewhere. This information may be incomplete, delayed or inaccurate, is provided for research and informational purposes only, and is not investment advice. The underlying ratings and opinions are those of the respective analysts and their firms; 13Foresight accepts no liability for any decisions made based on this data.